Pepper BioBiopharma1 / 15Read in the app

Pitch deck

Pepper Bio's pitch deck

The deck, and the round we watched Pepper Bio raise afterwards, with the investors each report named.

Pepper Bio is a biotechnology company based in Boston, founded in 2020. It is recognized as the world’s first transomics drug discovery company, utilizing AI and a proprietary database to uncover the root causes of diseases and expedite the development of effective treatments. The company operates with a dual business model, offering its AI-powered transomics platform to pharmaceutical companies and developing its own treatments for aggressive, untreatable cancers and other diseases. The core technology, known as the COMPASS platform, integrates four layers of biological data, genomics, transcriptomics, proteomics, and phosphoproteomics, to create a comprehensive map of cellular activity. This innovative approach allows researchers to identify new therapeutic targets and characterize potential drugs more effectively. Pepper Bio has secured exclusive global rights to develop and commercialize lerociclib, an oncology drug, and plans to begin clinical trials for its internal treatments following its recent funding round. The company collaborates with various partners, including Merck and G1 Therapeutics, to enhance drug discovery in complex disease areas.

15 slides2.8MBUSBiopharma

Read the deckFree account. The deck belongs to Pepper Bio, so reading it needs one; everything on this page is public.

What is in it

The deck, slide by slide

Each slide by what it argues. 15 slides against a median of 13 across the 1,712 decks we hold.

median
  1. 1Cover
  2. 2
  3. 3
  4. 4Solution
  5. 5Problem
  6. 6
  7. 7Product
  8. 8Contact
  9. 9Contact
  10. 10
  11. 11Product
  12. 12Product
  13. 13Market
  14. 14
  15. 15Product

CoverSolutionProblemProductContactMarket

  1. Nov 2023

    Seed$6.5M

    Mana VenturesNFXSilverton Partners

    Source recorded

Everyone who backed Pepper Bio

Form D

What they told the regulator

Pepper Bio filed 3 Form Ds with the SEC

The company reporting its own raise, rather than a journalist reporting it.

$3.6Msold under the offeringJan 2023most recent filing
Pepper Bio pitch deck, cover slide1 / 15

The deck itself

Read Pepper Bio's full pitch deck

All 15 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.

Read the deck →Free account. The deck belongs to Pepper Bio.

More decks

Browse all 1,712 decks. We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, tell us and it goes.